Annabel Chen

发表

A validated clinical and biochemical score for the diagnosis of acute heart failure: the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Acute Heart Failure Score.

U. Siebert, J. Januzzi, A. Baggish, 2006, American heart journal.

Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy.

D. Lloyd‐Jones, J. Januzzi, A. Baggish, 2005, American heart journal.

Differential responding for brain stimulation reward and sucrose in high-alcohol-drinking (HAD) and low-alcohol-drinking (LAD) rats.

M. J. Lewis, Regat Seyoum, J. Woods, 2003, Alcoholism, clinical and experimental research.

Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study.

D. Lloyd‐Jones, J. Januzzi, A. Baggish, 2006, Journal of the American College of Cardiology.

Association of atrial fibrillation and amino-terminal pro-brain natriuretic peptide concentrations in dyspneic subjects with and without acute heart failure: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study.

D. Lloyd‐Jones, M. O’Donoghue, J. Januzzi, 2007, American heart journal.

Usefulness of aminoterminal pro-brain natriuretic peptide testing for the diagnostic and prognostic evaluation of dyspneic patients with diabetes mellitus seen in the emergency department (from the PRIDE Study).

M. O’Donoghue, J. Januzzi, A. Baggish, 2007, The American journal of cardiology.

Amino-terminal pro-brain natriuretic peptide for the diagnosis of acute heart failure in patients with previous obstructive airway disease.

C. Camargo, J. Januzzi, A. Baggish, 2006, Annals of emergency medicine.

The NeuroAiD II (MLC901) in Vascular Cognitive Impairment Study (NEURITES)

N. Venketasubramanian, K. Ikram, Annabel Chen, 2013, Cerebrovascular Diseases.

APOE missense variant R145C is associated with increased Alzheimer's disease risk in African ancestry individuals with the APOE Ïµ3/Ïµ4 genotype

Michaël E. Belloy, M. Greicius, L. Farrer, 2021, medRxiv.